XCUR – Exicure Inc.
Exicure, Inc.XCUR
$1.08Name : Exicure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $7,069,675.00
EPSttm : -1.31
Exicure, Inc.
$1.08
21.31%$0.19
XCUR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
1.15
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
1.08
Target Price
10.33
Analyst Recom
1
Performance Q
-16.92
Upside
-1,664.8%
Beta
3.76
Ticker: XCUR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | XCUR | 1.075 | N/A | N/A | 0 |
| 2026-10-13 | XCUR | 1.15 | N/A | N/A | 0 |
| 2026-10-14 | XCUR | 1.225 | N/A | N/A | 0 |
| 2026-10-15 | XCUR | 1.11 | N/A | N/A | 0 |
| 2026-10-16 | XCUR | 1.11 | N/A | N/A | 0 |
| 2026-10-19 | XCUR | 1.065 | N/A | N/A | 0 |
| 2026-10-20 | XCUR | 1.01 | N/A | N/A | 0 |
| 2026-10-21 | XCUR | 1.0117 | N/A | N/A | 0 |
| 2026-10-22 | XCUR | 1.09 | N/A | N/A | 0 |
| 2026-10-23 | XCUR | 1.07 | N/A | N/A | 0 |
| 2026-10-26 | XCUR | 1.05 | N/A | N/A | 0 |
| 2026-10-27 | XCUR | 1.06 | N/A | N/A | 0 |
| 2026-10-28 | XCUR | 1.01 | N/A | N/A | 0 |
| 2026-10-29 | XCUR | 0.963 | N/A | N/A | 0 |
| 2026-10-30 | XCUR | 1.03 | N/A | N/A | 0 |
| 2026-11-02 | XCUR | 1.02 | N/A | N/A | 0 |
| 2026-11-03 | XCUR | 1.03 | N/A | N/A | 0 |
| 2026-11-04 | XCUR | 0.9928 | N/A | N/A | 0 |
| 2026-11-05 | XCUR | 0.905 | N/A | N/A | 0 |
| 2026-11-06 | XCUR | 0.9148 | N/A | N/A | 0 |
| 2026-11-09 | XCUR | 0.924 | N/A | N/A | 0 |
| 2026-11-10 | XCUR | 1.02 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | XCUR | 1.08 | - | - | - |
| 2026-10-13 | XCUR | 1.19 | - | - | - |
| 2026-10-14 | XCUR | 1.19 | - | - | - |
| 2026-10-15 | XCUR | 1.14 | - | - | - |
| 2026-10-16 | XCUR | 1.09 | - | - | - |
| 2026-10-19 | XCUR | 1.11 | - | - | - |
| 2026-10-20 | XCUR | 1.11 | - | - | - |
| 2026-10-21 | XCUR | 1.02 | - | - | - |
| 2026-10-22 | XCUR | 1.11 | - | - | - |
| 2026-10-23 | XCUR | 1.10 | - | - | - |
| 2026-10-26 | XCUR | 1.09 | - | - | - |
| 2026-10-27 | XCUR | 1.13 | - | - | - |
| 2026-10-28 | XCUR | 1.02 | - | - | - |
| 2026-10-29 | XCUR | 0.93 | - | - | - |
| 2026-10-30 | XCUR | 1.02 | - | - | - |
| 2026-11-02 | XCUR | 1.02 | - | - | - |
| 2026-11-03 | XCUR | 1.02 | - | - | - |
| 2026-11-04 | XCUR | 0.95 | - | - | - |
| 2026-11-05 | XCUR | 0.89 | - | - | - |
| 2026-11-06 | XCUR | 0.92 | - | - | - |
| 2026-11-09 | XCUR | 0.87 | - | - | - |
| 2026-11-10 | XCUR | 1.08 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | XCUR | 0.00 | -1.40 | 1.01 |
| 2026-10-13 | XCUR | 0.00 | -1.40 | 1.01 |
| 2026-10-14 | XCUR | 0.00 | -1.40 | 1.01 |
| 2026-10-15 | XCUR | 0.00 | -1.40 | 1.01 |
| 2026-10-16 | XCUR | 0.00 | -1.40 | 1.01 |
| 2026-10-19 | XCUR | 0.00 | -1.39 | 1.01 |
| 2026-10-20 | XCUR | 0.00 | -1.39 | 1.01 |
| 2026-10-21 | XCUR | 0.00 | -1.39 | 1.01 |
| 2026-10-22 | XCUR | 0.00 | -1.39 | 1.01 |
| 2026-10-23 | XCUR | 0.00 | -1.39 | 1.01 |
| 2026-10-26 | XCUR | 0.00 | -2.17 | 1.01 |
| 2026-10-27 | XCUR | 0.00 | -2.17 | 1.15 |
| 2026-10-28 | XCUR | 0.00 | -2.17 | 1.15 |
| 2026-10-29 | XCUR | 0.00 | -2.17 | 1.15 |
| 2026-10-30 | XCUR | 0.00 | -2.17 | 1.15 |
| 2026-11-02 | XCUR | 0.00 | -2.16 | 1.15 |
| 2026-11-03 | XCUR | 0.00 | -2.16 | 1.15 |
| 2026-11-05 | XCUR | 0.00 | -2.16 | 1.15 |
| 2026-11-06 | XCUR | 0.00 | -2.16 | 1.15 |
| 2026-11-09 | XCUR | 0.00 | -2.16 | 1.15 |
| 2026-11-10 | XCUR | 0.00 | -2.16 | 1.15 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-2.16
Beta
3.76
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
Sentiment Score
3
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.5
Target Price
10.33
P/E
Forward P/E
PEG
P/S
P/B
7.05
P/Free Cash Flow
EPS
-1.3
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
17.89
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
XCUR
Healthcare
$1.08
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
51.7
Range 1M
0%
Sup Dist
21.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
0%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+856.5% upside
Upside
+856.5%
Quality
7
XCUR — P/E HistoricalBiotechnology
Exicure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 1
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR
Latest News
—
Caricamento notizie per XCUR…
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading